SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019655
Filing Date
2024-05-15
Accepted
2024-05-15 13:00:43
Documents
54
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 735276
2 ex31-1.htm EX-31.1 13002
3 ex31-2.htm EX-31.2 9900
4 ex32-1.htm EX-32.1 7899
5 ex32-2.htm EX-32.2 7865
  Complete submission text file 0001493152-24-019655.txt   3176182

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ogen-20240331.xsd EX-101.SCH 27323
7 XBRL CALCULATION FILE ogen-20240331_cal.xml EX-101.CAL 36132
8 XBRL DEFINITION FILE ogen-20240331_def.xml EX-101.DEF 72748
9 XBRL LABEL FILE ogen-20240331_lab.xml EX-101.LAB 225761
10 XBRL PRESENTATION FILE ogen-20240331_pre.xml EX-101.PRE 161801
57 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 346306
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 24948854
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)